Sympfiny® Multiparticulate Drug Delivery System

• The international standard gives customers access to renewable alternatives
• Transparency through mass balancing creates customer confidence

Many nations are experiencing a major demographic shift in which the over-60 population will soon outweigh younger age groups. An aging population has increasing implications for the healthcare system, as older adults are at a greater risk of chronic disease and often experience challenges with non-adherence to multiple medications.

The Röchling Group is investing EUR 50 million in a new production building and production resources at its Röchling Medical site in Neuhaus am Rennweg, Germany. This is the world-leading plastics processor’s biggest investment to date in buildings and machinery. By making this investment, the Röchling Group is laying the course for the ongoing growth of its Medical division. The new building will create around 30 new jobs in Neuhaus, Thuringia.

Our sister GMP-sites in Brensbach and Neuhaus specialize in the development and manufacture of plastic primary packaging solutions for the pharmaceutical and diagnostic industries. We offer end-to-end support from product design to regulatory services.

Standard primary packaging solutions for solids, liquids and ophthalmologyContainers for diagnostics and analytics